On 7 July 2026, Cambrex announced that Snapdragon Chemistry, a Cambrex group company, and Q1 Scientific are being recognized for innovation and sustainability within the pharmaceutical sector. The announcement is framed around Cambrex’s role as a global contract development and manufacturing organization (CDMO) supporting pharmaceutical development and production.
According to the PR Newswire release, the company positions these recognitions as reflecting efforts to improve processes and outcomes in pharmaceutical manufacturing, including sustainable practices. The company also notes that Snapdragon Chemistry is collaborating with NewAmsterdam (as referenced in the release) as part of its broader work.
The publication presents these awards/recognitions as industry acknowledgements of the companies’ capabilities, while Cambrex links them to its own strategy and portfolio across development and manufacturing services. The information provided is promotional and does not specify the awarding body, award name, or detailed criteria in the excerpt available.
